Original source: https://www.investing.com/news/stock-market-news/kennedys-us-vaccine-panel-votes-in-favor-of-mercks-rsv-antibody-drug-4113185
Kennedy’s new US vaccine panel backs Merck’s RSV drug for infants
Tweet on Twitter
Share on Facebook
Google+
Pinterest